-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: February 2008
Diabetes: New Mechanisms, New Opportunities
Panelists in the diabetes panel stressed the importance of the growing prevalence of the disease – it’s expected to more than double by 2030. Those are big numbers, particularly because diabetes is the number one cause of preventable blindness. There is a light on the horizon – several new treatments for both Type 1 and Type 2 diabetes: XOMA – two current trials for Type 2 diabetes. XOMA’s drug could be administered once a month Read More >
Pain “A Pain Free” Guide
The CEO & Investor Conference started out strong with several therapeutic workshops. The Pain “A Pain Free“ Guide to Current Therapies panel shared efforts to develop drugs with greater efficiency and fewer side-effects, including a patch for the site of pain (NeurogesX, Inc.), the use of Morphine products for acute to moderate pain (Javelin Pharmaceuticals, Inc.), and low dosage steroids (CombinatoRX). Pain is the most common reasons patients seek medical attention and is one of the Read More >
10 Years and Counting!
There’s a reason why they call it ‘the largest investor conference focused on the biotech industry.’ The next few days will bring out the major players in biotech, from investors to venture capitalists to companies with innovations worthy of writing home about. And the Daily Update is your cheat sheet for getting late-breaking announcements from companies and highlights from each day’s sessions. Check out this blog when you’re not at the numerous roundtables & workshops, Read More >
Meet me at CEO
Two days until the CEO & Investor Conference! I’ll be there, will you?
